Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.

$32.4M

Market Cap • 12/26/2024

2015

(9 years)
Founded

2016

(8 years ago)
IPO

NASDAQ

Listing Exchange
Flag of US

New York

Headquarters • New York